tirzepatide and hormones FDA approval for Zepbound (tirzepatide) injection, the first only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide, Hormone Therapy Combination Increases

Intravenous (IV) Therapy: Glutathione administered through the intravenous delivery system gets into the veins to increase its absorption rate into the body system

Medication Mechanism of Action Average Weight Loss Retatrutide Triple agonist (GLP-1, GIP, Glucagon) Up to 24% average weight loss over 48 weeks Semaglutide GLP-1 receptor agonist Up to 17% over 68 weeks Tirzepatide Dual agonist (GLP-1, GIP) Up to 25% over 52 weeks Retatrutide is used to help with weight loss

Supplemental fiber, particularly soluble fiber sources, can break this cycle while also supporting healthy eating patterns

Contrave comes up regularly in those conversations, so heres what we tell patients face to face

FDA-Approved Peptides for Weight Loss As of now, two are FDA-approved specifically for chronic weight management in adults: Semaglutide (Wegovy): For BMI of 30 or higher, or 27-plus with a weight-related health condition Tirzepatide (Zepbound): Approved under similar criteria Both require a prescription

Those who have a history of urinary tract infections may want to avoid Ozempic, Smith said